Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The Company's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.As of 25 May 2026, ARVEE LABORATORIES I LTD share price is ₹163.81. The stock opened at ₹157.65, compared to its previous close of ₹157.65. During today's trading session, ARVEE LABORATORIES I LTD share price moved in the range of ₹157.65 to ₹164.40, with an average price of ₹161.03 for the day. Looking at its last 52-week, the stock has touched a low of ₹157.65 and a high of ₹164.40.
The market capitalization of ARVEE LABORATORIES I LTD is ₹174 Crs, with a P/E ratio of 68.8 and a dividend yield of 0.00%.